Working… Menu

Phase I Trial of VS-6063 and RO5126766. (FRAME)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03875820
Recruitment Status : Recruiting
First Posted : March 15, 2019
Last Update Posted : September 11, 2020
Verastem, Inc.
Chugai Pharmaceutical
Information provided by (Responsible Party):
Institute of Cancer Research, United Kingdom

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 12, 2021
Estimated Study Completion Date : July 12, 2021